Basel Medical Group issues 6M shares from warrants

Ordinary shares issued and outstanding totaled 13,582,111 as of October 29, 2026.

Available on EDGAR 10/29/2026 - 06:30 AM EDT Accepted by SEC EDGAR 10/29/2026 - 06:30 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Basel Medical Group Ltd (BMGL) reported that warrant holders exercised an aggregate of 6,000,000 Common Warrants using the zero cash exercise option, following its offering of 6,000,000 units, which closed October 9, 2026. The company issued 6,000,000 new ordinary shares from the exercises and received no new proceeds. Ordinary shares issued and outstanding totaled 13,582,111 as of October 29, 2026.

Filing Explained

The 6,000,000 warrant shares have already been issued, increasing the company’s share count and reducing existing holders’ percentage ownership absent offsetting changes; the company received no proceeds for these shares under the zero-cash exercise.

Key Figures

Common Warrants exercised: 6,000,000 warrants New ordinary shares issued: 6,000,000 shares Ordinary shares issued and outstanding: 13,582,111 shares +2 more

5 metrics

Common Warrants exercised 6,000,000 warrants Exercised using the zero cash exercise option

New ordinary shares issued 6,000,000 shares Issued pursuant to the warrant exercises

Ordinary shares issued and outstanding 13,582,111 shares As of October 29, 2026

Units in offering 6,000,000 units Offering closed October 9, 2026

Unit composition 1 ordinary share and 1 Common Warrant per unit Terms of the offering

Key Terms

Common Warrant, zero cash exercise option, issued and outstanding

3 terms

Common Warrant technical

"one warrant (“Common Warrant”)"

A common warrant is a tradable security that gives its holder the right to buy a company’s common shares at a preset price for a limited time. It matters to investors because exercising warrants can dilute existing ownership and create leverage: holders can benefit if the stock rises above the preset price, while holders of original shares face potential reduction in their percentage stake, similar to more tickets being added to a raffle.

zero cash exercise option technical

"each with the zero cash exercise option"

A zero cash exercise option lets a holder convert an option into shares without handing over money by surrendering a portion of the newly issued shares to cover the cost and any taxes, like getting an item by returning part of it instead of paying cash. For investors this matters because it changes how many new shares actually enter the market and whether a company needs cash to fulfill the grant, affecting ownership percentages and per-share metrics.

issued and outstanding financial

"Ordinary Shares issued and outstanding"

Issued and outstanding refers to two related counts of a company's stock: "issued" is the total number of shares the company has created and ever sold, while "outstanding" is the number of those shares currently held by outside investors (issued shares minus any the company holds in its treasury). Investors use outstanding shares to calculate ownership percentages, voting power, earnings per share and market capitalization — think of issued shares as all slices baked and outstanding as the slices actually on the table for people to eat.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BMGL warrants were exercised?

Holders exercised 6,000,000 Common Warrants using the zero cash exercise option, and Basel Medical Group issued 6,000,000 new ordinary shares.

Did the BMGL warrant exercises generate proceeds?

No. Basel Medical Group received no new proceeds from the warrant exercises.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File Number: 001-42527

Basel Medical Group Ltd

6 Napier Road,

Unit #02-10/11 Gleneagles Medical Centre

Singapore 258499

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Explanatory Note

Basel Medical Group Ltd (Nasdaq: BMGL), a British Virgin Islands business company (the “Company”), announced today that following the offer and sale of 6,000,000 units (the “Units”), each consisting of one ordinary share, no par value per share (each an “Ordinary Share” and collectively the “Ordinary Shares”) and one warrant (“Common Warrant”), each to purchase one Ordinary Share, which offering was closed on October 9, 2026, the Company has received exercise notices from the warrant holders, exercising an aggregate of 6,000,000 Common Warrants, each with the zero cash exercise option. No new proceeds were raised from the warrant exercises. The Company has issued a total of 6,000,000 new Ordinary Shares pursuant to such warrant exercises. As of October 29, 2026, the Company had a total of 13,582,111 Ordinary Shares issued and outstanding.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Basel Medical Group Ltd
By:	/s/ Alton Chun How Neo
Name:	Alton Chun How Neo
Title:	Interim Chief Financial Officer
Date:	October 29, 2026